Historically, access to methadone for the treatment of opioid addiction has been through enrollment in a local clinic licensed to dispense methadone. As a result of Covid restrictions, some of these clinic regulations were relaxed. For example, many patients across the U.S. were allowed to begin receiving take home doses of methadone as a result of Covid lockdowns and decreased clinic access.
Critics have begun to express the belief that clinic restrictions are cumbersome and that methadone should be made available for pick-up at local pharmacies. On the other hand, the concern remains that methadone can be misdirected or mishandled thus reinforcing the need for close supervision, particularly in the early phases of opioid treatment. Decades of research has shown that taken under proper supervision, methadone’s safety profile is excellent.
In this recent era of contaminated street opiates and overdose concerns, it is clear that methadone is a phenomenally effective medication for promoting health, well-being, and physical safety.
Mark Parrino, president of the American Association for the Treatment of Opioid Dependence, recently shared that deregulation of methadone would likely increase the diversion of methadone and methadone-related overdose deaths.
Following a period of stability, most U.S. clinics do allow patients to begin dosing at home with methadone. This system of care is working well throughout the country where methadone is readily available. However, many U.S. citizens are still lengthy distances from methadone-approved clinics. So, the challenge continues to link those with opioid addiction to effective resources in their local community. Legislators are presently examining a range of options as the opioid epidemic marches on.
Acadia Healthcare is one of America’s leading psychiatric and chemical dependency treatment providers. Headquartered in Franklin Tennessee, the company operates an extensive network of behavioral health facilities many of which focus specifically on the treatment of opioid use disorder.
Acadia’s CTC (Comprehensive Treatment Center) clinics specialize in helping patients who are struggling with an opioid addiction. Across Acadia’s network the company employees over 20,000 staff who serve about 70,000 patients on a daily basis.
Acadia’s dedicated CTC clinics utilize the best practice medication-assisted treatment (MAT) model which aims to stabilize patients using FDA-approved medications. These medications include methadone, buprenorphine, suboxone, and vivitrol.
Medication management allows Acadia patients to successfully ease their distressing withdrawal symptoms such that long-lasting addiction recovery can be established.
Because addiction can be a very individualized experience from one person to the next, Acadia’s treatment staff strive to individualize each patient’s treatment plan in a commitment to help each person meet their personal recovery goals.
Featured here on Methadone.US are 148 CTC clinics that Acadia provide across the United States. Feel free to browse Acadia’s network to locate a treatment facility near you, and make a new start! A great quote that we believe in goes like this “Today is the first day of the rest of your life”.
Acadia Healthcare is a leading provider of addiction treatment and behavioral healthcare services in the USA, the UK, and Puerto Rico. Worldwide, they operate a network of 593 facilities with 18,100 beds in 40 U.S. States. Of these locations, Acadia offer medication-assisted opioid treatment in 127 of their facilities.
While Acadia are experts in the treatment of opioid misuse disorders, they treat a wide variety of addiction-related problems utilizing traditional outpatient programs up to inpatient detoxification and residential treatment. You can view Acadia’s Levels of Care on their website to gain a better view of the breadth of their substance abuse services.